Lipocine to Present at H.C. Wainwright 27th Annual Global Investment Conference

SALT LAKE CITY, Sept. 5, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery, today announced that Company Management will present and meet with investors at the H.C. Wainwright 27^th Annual Global Investment Conference being held in-person and virtually on September 8-10, 2025.

Read more at prnewswire.com